Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06573606
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-21
Brief Title:
Ophthalmic Solution in Diabetic Corneal Alteration
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Ophthalmic Solution in Diabetic Corneal Alteration
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Data analyses and revision of the DED symptoms in diabetic subjects A novel ophthalmic solution containing cross-linked ha CX-HA and Chondroitin sulphate CS has been made available on the market
Both molecules have been widely studied for their viscoelastic and hydrating properties
Nevertheless the use of CS in ophthalmology has been limited since routinely the molecule is of animal origins
This new ophthalmic solution is the first on the market formulated with a CS of non-animal origin
Both molecules have been widely studied for their viscoelastic and hydrating properties
Nevertheless the use of CS in ophthalmology has been limited since routinely the molecule is of animal origins
This new ophthalmic solution is the first on the market formulated with a CS of non-animal origin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None